MDCX
Medicus Pharma Ltd.
1.90$
+2.7%
vs. previous close
Closing price · As of: Nov 2, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Medicus Pharma Ltd. (MDCX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/23/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Other Events; Financial Statements and Exhibits | View report ↗ |
| 10/16/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Financial Statements and Exhibits | View report ↗ |
| 10/07/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/14/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Termination of a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 09/14/2026 | Ownership disclosure | Form SC 13D filed with the SEC | View document ↗ |
| 09/11/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View report ↗ |
| 09/03/2026 | Current report (8-K) | Medicus Pharma Ltd. (MDCX): Entry into a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.